SC 13G: MACROGENICS INC
Ticker: MGNX · Form: SC 13G · Filed: 2024-02-14T00:00:00.000Z
Sentiment: neutral
Topics: sc-13g
AI Summary
SC 13G filing by MACROGENICS INC.
Risk Assessment
Risk Level: low
From the Filing
EDGAR Filing Documents for 0001897612-24-001224 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home Company Search Current Page Form SC 13G - Statement of Beneficial Ownership by Certain Investors: SEC Accession No. 0001897612-24-001224 Filing Date 2024-02-14 Accepted 2024-02-14 10:04:37 Documents 1 Confirming Copy Document Format Files Seq Description Document Type Size 1 mgnx13gdec23.txt SC 13G 4930 Complete submission text file 0001897612-24-001224.txt 6455 Mailing Address 9704 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 Business Address 9704 MEDICAL CENTER DRIVE Rockville MD 20850 301-251-5172 MACROGENICS INC (Subject) CIK : 0001125345 (see all company filings) EIN. : 000000000 | State of Incorp.: DE | Fiscal Year End: 1231 Type: SC 13G | Act: 34 | File No.: 005-87928 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences) Mailing Address 100 EAST PRATT STREET BALTIMORE MD 21202 Business Address 100 EAST PRATT STREET BALTIMORE MD 21202 000-000-0000 T. Rowe Price Investment Management, Inc. (Filed by) CIK : 0001897612 (see all company filings) EIN. : 854328500 | State of Incorp.: MD | Fiscal Year End: 1231 Type: SC 13G